Press release
Sickle Cell Disease Treatment Market Outlook 2034: From US$ 2.7 Billion in 2023 to US$ 17.7 Billion by 2034, Driven by Gene Therapies and Rising Awareness
Sickle Cell Disease Treatment Market
Access key findings and insights from our Report in this sample - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=65504
Market Overview
The SCD Treatment Market includes treatments like blood transfusions, pharmacotherapy (e.g., hydroxyurea, voxelotor), bone marrow transplants, and emerging gene therapies (e.g., Casgevy, Lyfgenia). Valued at US$ 2.7 billion in 2023, it is expected to reach US$ 17.7 billion by 2034 at a CAGR of 18.5%. The market is segmented by treatment type (blood transfusion, pharmacotherapy, bone marrow transplant, gene therapy), disease type (sickle cell anemia, hemoglobin SC, others), end-user (hospitals, specialty clinics, others), route of administration (oral, parenteral), and region (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa). Blood transfusions held a 49.5% share in 2023, while gene therapies are the fastest-growing segment.
Key Drivers of Growth
Several factors are propelling the SCD Treatment Market:
Gene Therapy Breakthroughs: Approvals of Casgevy and Lyfgenia (2023) using CRISPR and viral delivery offer potential cures, with 96.6% of Casgevy trial participants achieving vaso-occlusive crisis-free outcomes for 12 months.
Rising Prevalence: SCD affects 7.74 million people globally (2021), with a 41.4% increase since 2000, particularly in sub-Saharan Africa, India, and the Middle East.
Increased Awareness: Global initiatives, like India's National Sickle Cell Anaemia Elimination Program (2023), drive early diagnosis and treatment demand.
Healthcare Investments: Rising global healthcare spending, reaching US$ 9 trillion in 2020, supports R&D and infrastructure for SCD care.
Regulatory Support: FDA's RMAT and orphan drug designations, like for Editas Medicine's EDIT-301 (2023), accelerate novel therapy approvals.
Top Companies:
Bristol-Myers Squibb Company
CRISPR Therapeutics
Novartis AG
Emmaus Medical, Inc.
Bluebird bio Inc.
Hoffmann-La Roche Ltd.
Pfizer Inc.
Vertex Pharmaceuticals Incorporated
Agios Pharmaceuticals, Inc.
GlycoMimetics
Graphite Bio, Inc.
Mylan N.V.
Teva Pharmaceutical Industries Ltd.
AstraZeneca
Hikma Pharmaceuticals PLC
Addmedica
Other prominent plyers
Access our report for a comprehensive look at key insights - https://www.transparencymarketresearch.com/sickle-cell-disease-treatment-market.html
Challenges and Barriers
Despite its growth potential, the market faces several challenges:
High Treatment Costs: Gene therapies cost $2-$3 million per patient, limiting accessibility in low-income regions.
Limited Infrastructure: Inadequate healthcare facilities in Africa and parts of Asia-Pacific restrict treatment access.
Regulatory Complexities: Stringent FDA and EMA approvals increase costs and delay market entry for new therapies.
Side Effect Risks: Bone marrow transplants and gene therapies carry risks like graft-versus-host disease, impacting adoption.
Awareness Gaps: Low awareness in some regions delays diagnosis, particularly for adult SCD cases.
Regional Insights
The SCD Treatment Market exhibits distinct regional dynamics:
North America: Dominates with a 38% share in 2023, driven by advanced R&D, high prevalence (100,000 U.S. cases), and players like Bluebird Bio and Pfizer.
Europe: Significant share, with 70,000 cases and growth in Denmark at the highest CAGR, supported by EU orphan drug policies.
Asia-Pacific: Fastest-growing region with a projected CAGR of 20%, fueled by rising prevalence in India and healthcare investments.
Latin America: Moderate growth, with Brazil leading due to improving healthcare infrastructure. Cost barriers persist.
Middle East & Africa: Largest patient pool (80% of global cases in Africa), but limited infrastructure hinders growth.
Future Opportunities
The SCD Treatment Market offers several avenues for growth and innovation:
Gene Therapy Expansion: Scaling CRISPR-based therapies like EDIT-301 can offer long-term cures.
Emerging Markets: Improving healthcare access in Africa and India can tap into high-prevalence regions.
Novel Pharmacotherapies: Drugs like mitapivat (Agios, Phase 2/3 trial 2023) target symptom relief and disease modification.
Digital Diagnostics: Non-invasive, point-of-care devices using densitometry and microfluidics can boost diagnosis rates.
Collaborations: Partnerships, like Novartis with the Bill & Melinda Gates Foundation (2021), can enhance therapy development.
More Trending Reports by Transparency Market Research -
Gene Delivery System Market: https://www.globenewswire.com/news-release/2024/02/13/2828427/32656/en/Gene-Delivery-System-Market-Size-to-Touch-Around-USD-10-0-billion-at-a-CAGR-of-7-2-from-2023-to-2031-Report-by-Transparency-Market-Research-Inc.html
Biopharmaceutical Fermentation Systems Market: https://www.globenewswire.com/news-release/2024/03/01/2838573/32656/en/Biopharmaceutical-Fermentation-Systems-Market-Projected-to-Reach-USD-52-6-billion-by-2031-with-a-CAGR-of-9-5-Report-by-Transparency-Market-Research-Inc.html
About Transparency Market Research
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Contact:
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Email: sales@transparencymarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Sickle Cell Disease Treatment Market Outlook 2034: From US$ 2.7 Billion in 2023 to US$ 17.7 Billion by 2034, Driven by Gene Therapies and Rising Awareness here
News-ID: 4113559 • Views: …
More Releases from Transparency Market Research
A2P SMS Market Outlook 2035: Expanding from US$ 71.2 Bn in 2024 to US$ 117.0 Bn …
The global Application-to-Person (A2P) SMS market is entering a phase of steady and resilient expansion, driven by the growing need for secure, reliable, and real-time communication between enterprises and consumers. Valued at US$ 71.2 Bn in 2024, the market is projected to reach US$ 117.0 Bn by 2035, expanding at a CAGR of 4.2% from 2025 to 2035. Despite the rise of internet-based messaging platforms, A2P SMS continues to maintain…
Global Methanol Market to Reach USD 32.9 Billion by 2034, Growing at 3.4% CAGR | …
The global methanol market was valued at US$ 22.0 billion in 2023 and is expected to witness steady expansion over the next decade. According to industry analysis, the market is projected to grow at a compound annual growth rate (CAGR) of 3.4% from 2024 to 2034, reaching an estimated US$ 32.9 billion by the end of 2034. This growth trajectory reflects the increasing relevance of methanol as a versatile chemical…
Methanol-to-Olefins Market Poised for Sustainable Growth, Set to Reach USD 44.1 …
The global Methanol-to-Olefins (MTO) market is witnessing a strong transformation as industries increasingly shift toward sustainable feedstocks and alternative non-petroleum chemical pathways. Valued at US$ 24.5 billion in 2023, the market is projected to expand at a compound annual growth rate (CAGR) of 5.5% from 2024 to 2034, reaching an estimated US$ 44.1 billion by the end of 2034. This growth trajectory highlights the strategic importance of MTO technology in…
Global Methyl Chloride Market Outlook 2035: Expanding Silicone Demand and Indust …
The global methyl chloride market was valued at US$ 2.2 billion in 2023 and is poised for steady expansion over the coming decade. According to the latest industry outlook, the market is projected to grow at a compound annual growth rate (CAGR) of 5.1% from 2024 to 2035, reaching an estimated US$ 4.1 billion by the end of 2035. This sustained growth reflects the compound's critical role as a chemical…
More Releases for Treatment
Trigeminal Neuralgia Treatment Market Size, Trigeminal Neuralgia Treatment Marke …
Trigeminal Neuralgia Treatment Market Dynamics are clarified by an in-depth review of facts on current and emerging trends. To understand a resource, the paper uses Porter's five forces to examine the importance of numerous qualities such as understanding of suppliers and customers, dangers provided by various agents, competitive strength, and promising new businesses. precious. Furthermore, the study covers numerous firms' Trigeminal Neuralgia Treatment research data, benefit, gross margin, worldwide market…
Medical Tourism Market Report by Treatment Type (Dental Treatment, Cosmetic Trea …
The global medical tourism market accounted for $104.68 billion in 2019, and is projected to reach $273.72 billion by 2027, registering a CAGR of 12.8% from 2019 to 2027 in terms of value.
View Full Report: https://reports.valuates.com/market-reports/ALLI-Auto-0P310/medical-tourism
In terms of volume, the global medical tourism market accounted for 23,042.90 thousand patients in 2019, and is projected to reach 70,358.61 thousand patients by 2027, registering a CAGR of 15.0% from 2019 to…
Stretch Marks Treatment Market by Treatment & Forecast - 2025
Global Stretch Marks Treatment Market: Snapshot
In order to expand their outreach and add to their product portfolio, keen players in the global stretch marks treatment market are taking the inorganic route of acquisitions. They are also pouring money into development of new and better products.
Rising instances of obesity causing stretch marks is serving to catalyze growth in the market. In addition, growing aesthetic consciousness among people, especially among pregnant women,…
Stretch Marks Treatment Market by Treatment & Forecast - 2025
Global Stretch Marks Treatment Market: Snapshot
In order to expand their outreach and add to their product portfolio, keen players in the global stretch marks treatment market are taking the inorganic route of acquisitions. They are also pouring money into development of new and better products.
Rising instances of obesity causing stretch marks is serving to catalyze growth in the market. In addition, growing aesthetic consciousness among people, especially among pregnant women,…
Medical Tourism Market by Treatment Type (Dental Treatment, Cosmetic Treatment, …
Medical Tourism Market Overview:
The global medical tourism market was valued at $53,768 million in 2017, and is estimated to reach at $143,461 million by 2025, registering a CAGR of 12.9% from 2018 to 2025.
Organized travel across international borders to avail medical treatment of some form, which may or may not be available in the travelers home country is defined as medical tourism. Medical tourists travel abroad for the maintenance, enhancement,…
Substance Use Disorder Treatment Market By Type (Alcohol abuse treatment, Nicoti …
According to World Health Organization (WHO), the leading cause of disability around the world is not a physical disease, but a serious mood disorder known as depression. Around 350 million people suffer from depression worldwide, and that only about 50% of these individuals will ever receive treatment. According to Anxiety and Depression Association of America, in the U.S., over 15 million adults experience an episode of clinical depression in any…
